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Abstract
Background: Amental disorder is a psychiatric disease that presents asmild or severe
disturbances in a person’s behavior, mood, or thought. Mental illnesses are very
common because of excessive stress. Recent studies show that mental illnesses
are on the rise generally because of increasing stress. In Nigeria, medical records
suggest an upsurge in mental health cases since the onset of the country’s economic
downturn and the consequent trauma following it. The erythrocyte sedimentation
rate (ESR) is an indirect marker of serum acute-phase protein concentrations,
whereas C-reactive protein (CRP) is a direct protein measurement and it is inherently
more well-defined. This study thus evaluated the roles of ESR and CRP as sensitive
markers of inflammation and correlated their levels with severity stratification and
prognosis in schizophrenic patients.
Materials and Methods: This is a case-control study, and it was carried out on 40
patients diagnosed with schizophrenia. Thirty (30) controls were matched for age
and sex; 8 millimeters of venous blood was collected from each participant using
ante-cubital veins. Samples collected were dispensed into appropriate bottles for
analysis of CRP and hematological parameters using standard laboratory procedures.
Statistical analysis of the data was done appropriately and P-value of less than 0.05
was considered as significant.
Results: At the end of the study, the mean granulocytes, ESR, and CRP were
significantly higher in schizophrenia cases than in the controls, while the mean PCV,
RBC, and hemoglobin were significantly lower in the subjects. CRP had a higher area
than ESR under the ROC curve (AUROC).
Conclusion: This study thus evaluated the role of ESR and CRP as sensitive markers
of inflammation and acute phase reactants in schizophrenic patients. The findings
showed that CRP was a better diagnostic or predictor treatment outcome of
schizophrenia.
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1. Introduction
Schizophrenia is a mental disorder that is characterized by a breakdown of thought
processes and by poor emotional responsiveness, with mild or severe disturbances
in a person’s behavior, mood, or thought [1]. Even though schizophrenia has long
been described as a disease of ‘unknown etiology’ [2], it had been documented to
be associated with multiple genetic and environmental risk factors, including drug
and alcohol abuse, prenatal infections, and malnutrition [1, 3]. Generally, a mental
disorder appears in late adolescence or early adulthood. However, it can emerge at
any time in life. Its common features include auditory hallucinations, paranoid or bizarre
delusions, or disorganized speech and thinking, accompanied by significant social or
occupational dysfunction [1, 4]. Most people feel that mental disorders are rare and
would not happen to them or the members of their family. This is largely incorrect!
Mental illnesses are very common. About 30% of Nigerians suffer from or are liable
to different mental disorders, but the majority of them are undiagnosed [5]. Nigeria
with a population of nearly 170 million has about 1.7 million people suffering from
schizophrenia [6]. This figure reached before 2014 has risen to a new level following
the economic slump and the accompanying stress the country has suffered since 2016
which can lead to a state of depression. Depression is a state of lowmood and aversion
to activity that affects thoughts, behavior, and physical well-being [7]. It remains a
health issue of public importance. It affects about 121 million people and is recognized
as the leading cause of disability worldwide [8]. Absolute poverty, limited public health
services, civil unrest, gender inequality, andmultiple medical problems are some of the
identified causes of depression [9].
Despite decades of intensive research, diagnosis, and identification of patients with
severe form of depression, it still remains a challenge due to the lack of routinely
effective laboratory tests. This is further compounded by the unfavorable progno-
sis of depression as relapse/recurrence rate could be as high as 87% over 15 years
with at least 40% not responding to initial treatment [10]. The search for serum-
based biological marker for the diagnosis of depression or schizophrenia has been
on since 1960 when urinary excretion of metabolites of catecholamines, particularly
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norepinephrine, was used to classify major mood disorders [11]. Laboratory investiga-
tions have linked mental problems with excessive stress. High cortisol levels reflect a
higher degree of stress, but are dependent on the integrity of the HPA-axis [12]. Also,
elevated plasma levels of arginine vasopressin (AVP) which is another stress hormone
produced through HPA axis activity has been reported in schizophrenic patients [13].
Copeptin is a sensitive and stable surrogate marker for AVP release. It reflects the
individual stress level that plays a major role in depression and schizophrenia [5, 14].
Acute phase proteins (APP) are blood proteins primarily synthesized by hepatocytes
as part of the acute phase response (APR). The APR is a part of the early defense
or innate immune system, which is triggered by different stimuli including trauma,
infection, stress, neoplasia, and inflammation. The APR results in a complex systemic
reaction with the goal of re-establishing homeostasis and promoting healing [15]. CRP
has been inherently well-defined as a direct marker of acute protein measurement,
while erythrocyte sedimentation rate (ESR) is an indirect biomarker of serum acute-
phase protein concentrations. CRP is an acute phase reactant. It is a protein made by
the liver and released into the bloodstream within 24–48 hours after tissue injury, at
the start of an infection, or any inflammatory condition [16]. The level of CRP can rise
a thousand-fold in response to an inflammatory condition, and its rise in the blood
can precede pain, stress, or other clinical indicators [17]. CRP is not diagnostic of any
condition, but it can be used together with symptoms and other tests to evaluate an
individual for an acute or chronic inflammatory condition [18, 19]. CRP is a ‘marker’
for systemic inflammation [20], and thus would be useful as a prognostic marker in
management of schizophrenic subjects. ESR is a laboratory test that measures ery-
throcytes distance in a vertical tube (in millimeters) under the influence of gravity
force in one hour. It is a simple and an inexpensive test for an indirect measurement
of serum acute-phase protein concentrations that responds slowly to inflammatory
stimuli. The ESR depends on the aggregation of red blood cells (RBCs) and rouleaux
formation [21]. As a patient’s condition worsens or improves, the ESR responds slowly,
because fibrinogen, the major contributor to the short-term increase in ESR, has a half-
life of days (depending on other hemostatic factors), and immunoglobulins (strongly
contributing to the elevation of ESR in chronic inflammatory states) have half-lives
of weeks under normal physiologic states. This process can result in a significant lag
between clinical changes and ESR values [21]. This study will thus evaluate the roles
of ESR and CRP as both sensitive markers of inflammation and correlate their levels
with severity stratification and prognosis in mentally challenged patients.
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2. Materials and Methods
2.1. Study design
This is a case control study.
2.2. Subjects
The ethical approval with registration number ERC/2018/04/04/116B from the Federal
Teaching Hospital, Ido-Ekiti (FTHI) Ethics and Research Committee was duly obtained
for this study and also the informed consent or otherwise assent was taken from each
participant or relative, respectively. Thereafter, forty (40) schizophrenic subjects and
thirty (30) age- and sex-matched controls were randomly recruited into the study. All
the participants were between the ages of 18 and 70 years. The schizophrenic patients
were recruited from the Psychiatry Clinic of the FTHI, while the control group comprised
the members of the staff of the Hospital who had no symptoms of schizophrenia. The
schizophrenia group was diagnosed according to the Diagnostic and Statistical Manual
of Mental Disorders, fourth edition, text revision (DSM-4TR) by clinically trained and
experienced psychiatrists. A trained psychiatrist administered the Positive and Nega-
tive Syndrome Scale (PANSS) and recorded scores appropriately. PANSS is a medical
scale used for measuring symptom severity of patients with schizophrenia [22].
2.3. Inclusion criteria (cases and controls)
The criteria for the inclusion of cases were participants that gave informed consent,
satisfied PANSS for the diagnosis of schizophrenia, subjects whose positive and neg-
ative scales were ≤ 7 x ≥ 49 (Schizophrenia) and aged 18 to 70 years. The criteria for
the inclusion of controls were participants aged 18 to 70 years and whose PANSS scale
score was less than 7 (Schizophrenia).
2.4. Exclusion criteria (cases and controls)
The criteria for the exclusion of cases and controls were geriatric subjects (> 70 years)
and subjects less than 18 years, subjects with concurrent use of non-steroidal anti-
inflammatory agents, steroids, antidepressants, antipsychotic medications, and anti-
convulsants 3 weeks before presentation, subjects with previous history of mania or
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hypomania, or any concurrent psychotic symptoms, subjects with pregnancy, presence
of serious and/or unstable medical disorders, previous history of Addison’s disease,
Cushing’s disease or thyroid diseases or diabetic and hypertensive subjects.
2.5. Collection/sampling technique and storage of sample
Eight milliliters (8 ml) of venous blood was collected from each subject using aseptic
procedure. Two (2 ml) of venous blood was dispensed into a sterile ESR bottle contain-
ing 3.2% tri-sodium citrate solution in a ratio of blood-citrate, 5:1 (v/v) as an anticoag-
ulant and gently mixed by inverting the container several times for the determination
of ESR; 3 ml of the samples collected was dispensed into plain bottles and allowed
to retract. Each sample was spun at 4000 rpm for 5 minutes to obtain serum that
was stored at –20C until analysis. Similarly, three milliliters (3 ml) of venous blood left
overwas dispensed into ethylene diamine acetate bottle for hematological parameters
analysis.
2.6. Analytical methods and procedures
The serum level of CRP was determined using enzyme immunosorbent assay (ELISA)
as described by Johnson et al. [23], and standardmethodswere employed to determine
ESR and full blood count (FBC), using Westergren method and hematological analyzer,
respectively.
2.7. Statistical analysis
A statistical package for social scientist (SPSS) 23.0 version was used for the appropri-
ate analysis of the data. The distribution of the variables was assessed using histogram
with standard curve. Variables with Gaussian distribution were compared between
groups using Student’s t-test. However, to adjust for confounding factors, Analysis of
variance (ANOVA) was used to compare differences between the schizophrenic groups
based on the year of diagnosis. A graphical plot of sensitivity (Receiver Operating
Curve; ROC) was done and an area under ROC (AUROC) of each marker (CRP and ESR)
was compared using pair-wise comparison. Spearman correlation was used to test
the association between inflammatory markers (CRP and ESR) and other variables in
exposed groups. P-values less than 0.05 was considered significant.
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3. Results
A total number of 70 subjects were studied. They comprised 40 schizophrenic subjects
with mean age of 40.65 ± 12.32 years and 30 controls with mean age of 38.33 ±
11.93 years. Figure 1 shows the age and sex distribution of the recruited population in
percentage (%). There were 16 females and 24 males in the schizophrenic group, and
13 females and 17 males in the non-schizophrenic groups. Thus, females constituted
41.42%, while males constituted 58.58% overall. Comparing the mean hematological
parameters and CRP in schizophrenic subjects and controls using independent student
T-test, the mean GRA, ESR, and CRP were significantly higher among schizophrenia,
while themean PCV, RBC, and HBGwere significantly lower (Table 1). The schizophrenic
subjects were further classified into five groups based on the years of diagnosis. It was
observed, as shown in Table 2, that there were no significant differences in the mean
of hematological indices and CRP within the three groups, using One Way Analysis of
Variance (ANOVA).
Table 3 shows spearman correlation between hematological parameters with ESR
and CRP schizophrenic subjects. CRP showed positive correlation with GRA and nega-
tive correlation with LYMP, while ESR only had inverse correlation with PCV, RBC, and
HGB. The diagnostic performance of ESR and CRP were determined. CRP had higher
Area under the ROC curve (AUROC) than ESR as shown in Figure 2.
Figure 1: Age and Sex distribution of the recruited population in percentage (%).
4. Discussion and Conclusion
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T 1: Comparison of mean age, hematological parameters, and CRP among schizophrenic and non-
schizophrenic subjects.
Parameters Schizophrenic
subjects (n = 40)
Non-schizophrenic
subjects (n = 30)
P-value Rmk
Age (Years) 40.65 ± 12.32 38.33 ± 11.93 0.433 NS
PCV(%) 38.34 ± 4.09 40.89 ± 2.85 0.005 S
RBC (X 1012/L) 4.38 ± 0.50 4.76 ± 0.49 0.003 S
HBG (g/dl) 12.83 ± 1.38 13.49 ± 1.17 0.040 S
MCV (fl) 88.28 ± 6.00 85.80 ± 4.87 0.069 NS
MCH (pg) 29.18 ± 2.75 28.46 ± 2.20 0.243 NS
MCHC (g/dl) 32.93 ± 1.21 33.00 ± 0.98 0.792 NS
TWBC (X 109/L) 6.30 ± 1.91 6.07 ± 1.57 0.591 NS
LYMP (%) 40.37 ± 10.22 44.05 ± 10.13 0.139 NS
GRA (%) 48.32 ± 9.53 43.91 ± 8.22 0.046 S
PLT (X 109/L) 178.53 ± 59.06 205.30 ± 61.45 0.069 NS
ESR (mm/Hr) 37.73 ± 23.33 12.20 ± 9.06 0.000 S
CRP (µg/ml) 1.27 ± 0.32 1.07 ± 0.12 0.002 S
Note: *Significant at P ≤ 0.05.
PCV = Packed cell volume; RBC = Red blood cell; HGB = Hemoglobin concentration; MCV =
Mean cell volume; MCH = Mean cell haemoglobin; MCHC = Mean cell hemoglobin concentration;
TWBC = Total white blood cell; LYMP = Lymphocyte; GRA = Granulocytes; PLT = Platelets; ESR =
Erythrocytes sedimentation rate; CRP = C-reactive protein; Rmk = Remark; S = Significant; and
NS = Not significant.





0–5 (n = 20) 6–10 (n = 7) 11–15 (n = 4) 16–20 (n = 6) > 20 (n = 3) p-value
Age (Years) 38.75 ± 12.20 38.71 ± 14.44 39.25 ± 14.32 47.17 ± 3.66 46.67 ± 18.61 0.562
PCV (%) 38.58 ± 4.47 37.40 ± 4.45 37.28 ± 2.94 39.57 ± 2.58 37.90 ± 6.00 0.877
RBC (X 1012/L) 4.42 ± 0.56 4.30 ± 0.54 4.31 ± 0.29 4.36 ± 0.45 4.48 ± 0.64 0.978
HBG (g/dl) 13.00 ± 1.54 12.34 ± 1.71 12.58 ± 0.95 13.12 ± 0.99 12.63 ± 0.74 0.824
MCV (fl) 88.90 ± 5.85 86.71 ± 9.09 86.25 ± 4.57 90.17 ± 4.07 86.67 ± 4.73 0.763
MCH (pg) 29.68 ± 2.61 28.64 ± 3.93 28.20 ± 2.11 29.63 ± 1.55 27.50 ± 3.55 0.625
MCHC (g/dl) 33.19 ± 1.16 32.90 ± 1.28 32.83 ± 0.97 32.73 ± 0.84 31.77 ± 2.21 0.443
TWBC (X 109/L) 6.24 ± 1.78 6.71 ± 2.47 5.71 ± 1.42 6.55 ± 2.35 5.96 ± 2.06 0.929
LYMP (%) 39.50 ± 10.96 42.71 ± 9.87 33.93 ± 10.13 45.38 ± 6.59 39.23 ± 12.41 0.483
GRA (%) 48.19 ± 10.78 47.10 ± 8.56 54.33 ± 6.06 44.70 ± 6.41 51.20 ± 12.65 0.604
PLT (X 109/L) 181.45 ± 65.17 176.00 ± 63.70 182.50 ± 80.69 175.50 ± 46.12 165.67 ± 2.52 0.994
ESR (mm/Hr) 32.50 ± 22.96 41.86 ± 24.51 34.50 ± 23.24 42.00 ± 22.76 58.67 ± 23.69 0.432
CRP (µg/ml) 1.33 ± 0.31 1.25 ± 0.44 1.19 ± 0.19 1.18 ± 0.23 1.17 ± 0.32 0.865
Note: *Significant at P ≤ 0.05.
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T 3: Correlation between inflammatory markers, weight, body mass index, fasting blood sugar, and
oxidative stress parameters in exposed groups.
ESR R-value p-value CRP r-value p-value
Age (Years) 0.071 0.662 –0.186 0.249
PCV (%) –0.566 0.000* –0.032 0.845
RBC (X 1012/L) –0.578 0.000* 0.049 0.766
HBG (g/dl) –0.523 0.001* 0.043 0.793
MCV (fl) 0.171 0.292 –0.072 0.660
MCH (pg) 0.064 0.696 –0.029 0.857
MCHC (g/dl) –0.126 0.437 0.138 0.396
TWBC (X 109/L) 0.234 0.146 –0.184 0.256
LYMP (%) –0.049 0.766 –0.264 0.027*
GRA (%) 0.171 0.292 0.262 0.029*
PLT (X 109/L) –0.046 0.778 –0.044 0.790
ESR (mm/Hr) 1.000 - –0.213 0.186
Note: *Correlation is significant at the 0.05 level (2-tailed).
Figure 2: The ROC curve of blood levels of CRP and ESR schizophrenic subjects.
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4.1. Discussion
Figure 1 shows the age and sex distribution of the recruited population in percentage
(%). A total number of seventy (70) subjects consisted of forty (40) schizophrenic
subjects with mean age of 40.65 ± 12.32 years and thirty (30) control groups with
mean age of 38.33 ± 11.93 years were studied. The subjects constituted of 41.42%
and 58.58% females and males, respectively, overall; 31.42% of schizophrenic subjects
in this study were youths within the age bracket of 18–40 years. The major cause
of mental challenge in Nigeria is traceable to either drug abuse, abject poverty, or
any daily activities that could lead to depression [6]. Despite decades of intensive
research, diagnosis, and identification of patientswith severe form ofmental disorders,
it remains a challenge due to the lack of routinely useful laboratory test. There remains
an urgent need to identify biomarkers that can determine the severity, aid in diagnosis,
and probably predict the outcome of the treatment of these disorders.
The data in this study showed that the mean levels of granulocytes (GRA), ESR and
C-reactive protein (CRP) were significantly higher in schizophrenic group in comparison
with non-schizophrenic groups, while the mean PCV, RBC, and HBG were significantly
lower among schizophrenic group. CRP is an acute phase reactant, produced by some
inflammatory stimuli in the liver. It is mainly induced by interleukin 6 (IL-6), which is
pro-inflammatory cytokines released into the bloodstream [16, 24]. CRP is a ‘marker’
for systemic inflammation [20], and thus would be useful as a prognostic marker
in the management of schizophrenic subjects. Increase in the mean levels of CRP
in schizophrenia cases observed in this work is consistent with recent work where
elevated levels of some inflammatory biomarkers, such as TNF-α, was reported in
schizophrenic patients [25, 26].
In the same vein, increase in mean levels of ESR observed among schizophrenia
cases in comparison with control group confirms ESR roles as indirect marker of APP
even though its response to inflammatory stimuli might be slow [27]. As a patient’s
condition worsens or improves, the ESR responds slowly, and thus elevated ESR has
been reported to strongly contribute to chronic inflammatory states of the condition
[21]. Melamed and Sirota [28] revealed that ESR increased in 17% of the patients with
acute psychosis, which decreased to normal values after eight weeks of antipsychotic
treatment in two-thirds of those patients, with the reduction of psychopathological
manifestations. Here, using ESRwith othermarkers, having a high ESRwithout a known
physical illness might possibly serve as a biological indication of the remission and
relapse of the disease.
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Results showed that CRP had a positive correlation with GRA, and ESR had a nega-
tive correlation with packed cell volume (PCV), red blood cells (RBC), and hemoglobin
(HGB). Immune system dysfunctions and inflammatory processes show a link with the
pathogenesis of schizophrenia as reported by Richard and Brahm [29]. Granulocytes
are leukocytes of the innate immune system that have granules in their cytoplasm and
they are neutrophil, basophil, and eosinophil. We could speculate that positive correla-
tion between CRP and granulocytes are up-regulated as a compensatory mechanism
to cope with the condition or response to treatment. This confirms the roles of CRP and
granulocytes as acute protein reactant and immune system functions, respectively, in
the management of mentally challenged subjects. On the contrary, ESR had negative
correlation with PCV, RBC, and hemoglobin (HGB), and this corroborated the depen-
dence of ESR on the aggregation of RBCs and rouleaux formation as documented by
Calderon and Wener [21].
The diagnostic performance of ESR and CRP was determined using Area under the
ROC curve (AUROC). CRP had higher Area under the ROC curve (AUROC) than ESR as
shown in Figure 2. Even though ESR and CRP are both sensitive markers of inflamma-
tion and correlate with severity of inflammation, they are not specific to any particular
illness [21]. The high levels of CRP in central nervous system have been reported to
play an important role in some psychiatric dysfunctions, such as schizophrenia [30].
Similarly, Wang et al. [24] also reported that sensitivity analysis showed that serum
and plasma CRP levels were increased moderately in studies involving only high-
sensitivity CRP assay. However, our finding, when we determined the diagnostic and
prognostic performance of CRP and ESR using AUROC, showed that CRP, comparedwith
ESR, had better performance. Thus, this finding is certainly of clinical importance since
the measurement of CRP is widely available and affordable. Using CRP with symptoms
and other laboratory tests to predict or monitor the treatment of schizophrenia would
certainly improve the treatment condition of schizophrenic patients.
4.2. Conclusion and recommendation
This study thus evaluated the roles of ESR and CRP as sensitive markers of inflam-
mation and acute phase reactants in schizophrenic patients. Also, CRP was found to
be a better diagnostic or predictor treatment outcome of schizophrenia. This would
definitely improve the treatment of psychiatric patients as well as prevent relapse and
recurrence in the long term.
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